Showing results (2071-2080 of 2,670) with videos related to
Sort By:
Pageof 267
Journal of Neurochemistry|June 5, 2001
Constitutive expression of functional GABA(B) receptors in mIL-tsA58 cells requires both GABA(B(1)) and GABA(B(2)) genesB M Chronwall, T D Davis, M W Severidt, et al.JAMA Dermatology|May 28, 2025
Comparison of Botulinum Toxin A Formulations for Glabellar Strain Treatment in Women: A Double-Blind Randomized Clinical TrialMehdi S Lemdani, Stephanie E Honig, Theodore E Habarth-Morales, et al.FEBS Letters|November 18, 1991
A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuliR E Muid, M M Dale, P D Davis, et al.Frontiers in Oncology|February 3, 2023
Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myelomaKrystle L Ong, Marcus D Davis, Kalyn K Purnell, et al.CPT: Pharmacometrics & Systems Pharmacology|July 1, 2026
Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug ProductsSébastien Bihorel, Joannellyn Chiu, Jason Chittenden, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2011
Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapyJoe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.Helicobacter|November 25, 2003
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studiesWieslaw J Bochenek, Suzanne Peters, Polly D Fraga, et al.Investigational New Drugs|January 1, 1984
Tiazofurin: a new antitumor agentP J O'Dwyer, D D Shoemaker, H N Jayaram, et al.Current Medicinal Chemistry|March 23, 2004
4-thiophenoxy-N-(3,4,5-trialkoxyphenyl)pyrimidine-2-amines as potent and selective inhibitors of the T-cell tyrosine kinase p56lckD F C Moffat, R A Allen, S E Rapecki, et al.Journal of Clinical Pharmacology|August 8, 2013
Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, onartuzumab (MetMAb), in patients with advanced solid tumorsYan Xin, Denise Jin, Stephen Eppler, et al.Pageof 267